Safety and mortality outcomes for direct oral anticoagulants in renal transplant recipients.

Christine FirthFadi ShamounMichael ApolinarioElisabeth S LimNan ZhangMira T Keddis

Published in: PloS one (2023)

DOACs did not have inferior bleeding or mortality outcomes compared to warfarin in RTRs. There was greater use of warfarin compared to DOACs and a high rate of improper DOAC dose reduction.

Keyphrases

direct oral anticoagulants
atrial fibrillation
venous thromboembolism
cardiovascular events
risk factors
adipose tissue
oral anticoagulants
coronary artery disease
type diabetes
insulin resistance
metabolic syndrome
skeletal muscle
glycemic control